Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects.
about
Disease-modifying treatments for multiple sclerosis - a review of approved medicationsEndogenous Generation and Signaling Actions of Omega-3 Fatty Acid Electrophilic DerivativesPreferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic ImplicationsUtilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other DiseasesChemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cellsIdentification of protein succination as a novel modification of tubulinFumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report.Positively Charged Oligo[Poly(Ethylene Glycol) Fumarate] Scaffold Implantation Results in a Permissive Lesion Environment after Spinal Cord Injury in RatTreatment of Neuropathic Pain and Functional Limitations Associated With Multiple Sclerosis Using an MRI-Compatible Spinal Cord Stimulator: A Case Report With Two Year Follow-Up and Literature Review.Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesisTecfidera(®): an approach for repurposing.The glutathione system: a new drug target in neuroimmune disorders.Metabolic and safety issues for multiple sclerosis pharmacotherapy--opportunities for personalised medicine.Regulation of human glia by multiple sclerosis disease modifying therapies.Advancing drug delivery systems for the treatment of multiple sclerosis.The future of multiple sclerosis treatments.Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells.Targeting the Nrf2-Heme Oxygenase-1 Axis after Intracerebral Hemorrhage.Monomethyl fumarate inhibits pain behaviors and amygdala activity in a rat arthritis model.To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis.Lipid nanoparticles for administration of poorly water soluble neuroactive drugs.Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives.Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data.Dimethyl fumarate attenuates reactive microglia and long-term memory deficits following systemic immune challenge.γ-tubulin as a signal-transducing molecule and meshwork with therapeutic potentialGlutathione de novo synthesis but not recycling process coordinates with glutamine catabolism to control redox homeostasis and directs murine T cell differentiation
P2860
Q26777329-FFE65E60-57DB-4983-91A2-A96DA6FF175FQ26784513-B7D3B598-F22C-4CE5-A215-5BC81E3F6E7EQ27346374-204591EB-CBD9-425C-A920-E64AA5C4B0E4Q28078299-0CD2C230-068C-4F14-BCD0-72C066732DE5Q28078742-5D27E4AC-0BA7-4281-B1AD-53128438596FQ28821775-6A598B71-D26A-4222-97BC-A968F1E96138Q35073301-2CAA29E9-6338-4786-892C-A08C04BF8079Q35856171-F95375F5-88A0-4728-9A74-ED538293BDD5Q35862875-8131D493-E7DF-49AD-9DD5-A2E439671D66Q35865332-BF1120E3-B3EF-4562-B7FC-6BD8BB553AD1Q35971559-D9D6A707-0145-45BD-B844-666CED809483Q36067904-36A899D2-E48F-46AE-B657-299B416218ADQ38192708-4DE2F9B6-3192-4C07-B409-C9EE23B94641Q38206126-890C0FA5-CE5E-49C8-8113-B190B585FA97Q38218692-D8ABB4F1-E2C1-4B61-9ADB-91FCB2BDA5BFQ38563863-FCF97385-F842-4513-8F69-39CF09B55407Q38609620-D0F98B5F-BCE7-4EB5-A2AD-27A4ED89834EQ38808485-74967F9E-8231-49F6-9BEE-DA785ECABD94Q38992222-85CBCB6E-96D1-4873-869D-D4C923CCE3B1Q39230269-210B6C14-9AAA-49F5-8C34-8C65EB526561Q46317549-66C49FC8-D719-4D2A-B4A0-4635C695D5A6Q47859915-7289F071-C60E-4037-A32A-1AA414AF4907Q48034195-D6482E4A-080A-41EF-BDEC-6AF138073BD3Q48305463-6FAA15AE-0EDB-4790-951E-7C1EF387BF5DQ52332617-52B1EBB8-6636-46D2-BDD3-8A8318FE6722Q52806769-0EE3674B-D81C-4CC4-BA7B-96F991001965Q55121964-23CAE8C5-7D2E-480E-B78D-84EE74756756Q58741908-89B50CD2-ED7A-47E8-944E-E0A853837B0BQ58753648-51CB829E-5024-4A9D-8A68-89F0EA2D29D9
P2860
Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Dimethyl fumarate for treatmen ...... fectiveness, and side effects.
@en
type
label
Dimethyl fumarate for treatmen ...... fectiveness, and side effects.
@en
prefLabel
Dimethyl fumarate for treatmen ...... fectiveness, and side effects.
@en
P2860
P1476
Dimethyl fumarate for treatmen ...... fectiveness, and side effects.
@en
P2093
Ralf A Linker
P2860
P2888
P356
10.1007/S11910-013-0394-8
P577
2013-11-01T00:00:00Z
P6179
1026990816